Previous

E2 (Endovascular Engineering) Raises $80 Million Series C to Advance Next-Generation Thrombectomy Platform as Pulmonary Embolism Treatment Evolves
Next

Hydrolix Named to Inc. Regionals: Pacific List of Fastest-Growing Companies